GE Ventures launches new digital medicine company

GE Ventures and Stanford Health Care (affiliated with Stanford University) just announced the launch of digital medicine company Evidation Health. "Our company has the core capabilities to make precision digital medicine a reality. We envision a digital health-enabled future where clinical interventions can be customized and concentrated in ways that maximize clinical and economic benefit for payers, providers and, most importantly, patients," said Evidation Health CEO Deborah Kilpatrick. The company completed a Series A financing in January led by GE Ventures, and also including Asset Management Ventures and Rock Health. The company boasts partnerships with Humana ($HUM), Biogen Idec ($BIIB), Sanofi ($SNY), Harvard Business School and Wharton business school. More

Suggested Articles

They say you are what you eat, but scientists at Rice University and the University of Washington may be taking that maxim a step further.

Acutus secured $170 million after acquiring a catheter developer and announcing a slew of new partnerships in arrhythmia treatment and monitoring.

Tangen Biosciences, developers of cheap and portable molecular diagnostics for outside the lab, has raised $9 million to kick off its VC efforts.